Quarterly report pursuant to Section 13 or 15(d)

Segment reporting (Tables)

v3.8.0.1
Segment reporting (Tables)
9 Months Ended
Apr. 30, 2018
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment [Table Text Block] The following financial information represents the operating results of the reportable segments of the Company:

Three months ended April 30, 2018

    Clinical
Labs
    Life
Sciences
    Therapeutics     Other     Consolidated  
Revenues:                                        
Clinical laboratory services   $ 18,137                       $ 18,137  
Product revenues         $ 7,415                   7,415  
Royalty and license fee income           78                   78  
      18,137       7,493                   25,630  
Operating costs and expenses:                                        
Cost of clinical laboratory services     10,995                         10,995  
Cost of product revenues           3,562                   3,562  
Research and development           576     $ 223             799  
Selling, general and administrative     6,252       2,974           $ 1,799       11,025  
Provision for uncollectible accounts receivable     400       (4 )                 396  
Legal fee expense     25       19             1,607       1,651  
Total operating costs and expenses     17,672       7,127       223       3,406       28,428  
                                         
Operating income (loss)     465       366       (223 )     (3,406 )     (2,798 )
                                         
Other income (expense):                                        
Interest     (22 )     12             237       227  
Other     15       2                   17  
Foreign exchange loss           (462 )                 (462 )
Income (loss) before income taxes   $ 458     $ (82 )   $ (223 )   $ (3,169 )   $ (3,016 )
                                         
Depreciation and amortization included above   $ 437     $ 358     $     $ 20     $ 815  
                                         
Share-based compensation included in above:                                        
Selling, general and administrative     26     $ 17           $ 161       204  
Total   $ 26     $ 17     $     $ 161     $ 204  
                                         
Capital expenditures   $ 465     $ 96     $     $     $ 561  

Three months ended April 30, 2017

    Clinical
Labs
    Life
Sciences
    Therapeutics     Other     Consolidated  
Revenues:                                        
Clinical laboratory services   $ 19,584                       $ 19,584  
Product revenues         $ 7,312                   7,312  
Royalty and license fee income           193                   193  
      19,584       7,505                   27,089  
Operating costs and expenses:                                        
Cost of clinical laboratory services     11,334                         11,334  
Cost of product revenues           3,582                   3,582  
Research and development           552     $ 214             766  
Selling, general and administrative     6,118       2,745           $ 1,671       10,534  
Provision for uncollectible accounts receivable     650       (30 )                 620  
Legal fee expense     4       42             466       512  
Total operating costs and expenses     18,106       6,891       214       2,137       27,348  
                                         
Operating income (loss)     1,478       614       (214 )     (2,137 )     (259 )
                                         
Other income (expense):                                        
Interest     (28 )     12             131       115  
Other     7       (98 )           17       (74 )
Foreign exchange gain           147                   147  
Income (loss) before income taxes   $ 1,457     $ 675     $ (214 )   $ (1,989 )   $ (71 )
                                         
Depreciation and amortization included above   $ 390     $ 423     $     $ 37     $ 850  
                                         
Share-based compensation included in above:                                        
Cost of clinical laboratory services   $ 2                       $ 2  
Selling, general and administrative     38     $ 23           $ 146       207  
Total   $ 40     $ 23     $     $ 146     $ 209  
                                         
Capital expenditures   $ 483     $ 252     $     $     $ 735  

Nine months ended April 30, 2018

    Clinical
Labs
    Life
Sciences
    Therapeutics     Other     Consolidated  
Revenues:                                        
Clinical laboratory services   $ 58,001                       $ 58,001  
Product revenues         $ 21,618                   21,618  
Royalty and license fee income           639                   639  
      58,001       22,257                   80,258  
Operating costs and expenses:                                        
Cost of clinical laboratory services     34,767                         34,767  
Cost of product revenues           10,828                   10,828  
Research and development           1,690     $ 668             2,358  
Selling, general and administrative     18,454       8,487           $ 6,045       32,986  
Provision for uncollectible accounts receivable     2,000       (11 )                 1,989  
Legal fee expense     46       47             3,689       3,782  
Total operating costs and expenses     55,267       21,041       668       9,734       86,710  
                                         
Operating income (loss)     2,734       1,216       (668 )     (9,734 )     (6,452 )
                                         
Other income (expense):                                        
Interest     (70 )     35             604       569  
Other     32       10             44       86  
Foreign exchange gain           143                   143  
Income (loss) before income taxes   $ 2,696     $ 1,404     $ (668 )   $ (9,086 )   $ (5,654 )
                                         
Depreciation and amortization included above   $ 1,254     $ 1,039     $     $ 57     $ 2,350  
                                         
Share-based compensation included in above:                                        
Selling, general and administrative     86     $ 61           $ 470       617  
Total   $ 86     $ 61     $     $ 470     $ 617  
                                         
Capital expenditures   $ 1,459     $ 167     $     $     $ 1,626  

Nine months ended April 30, 2017

    Clinical
Labs
    Life
Sciences
    Therapeutics     Other     Consolidated  
Revenues:                                        
Clinical laboratory services   $ 56,979                       $ 56,979  
Product revenues         $ 21,721                   21,721  
Royalty and license fee income           933                   933  
      56,979       22,654                   79,633  
Operating costs and expenses:                                        
Cost of clinical laboratory services     33,282                         33,282  
Cost of product revenues           10,411                   10,411  
Research and development           1,695     $ 376             2,071  
Selling, general and administrative     17,967       8,596           $ 6,683       33,246  
Provision for uncollectible accounts receivable     1,910       58                   1,968  
Legal fee expense     105       70             1,079       1,254  
Total operating costs and expenses     53,264       20,830       376       7,762       82,232  
                                         
Operating income (loss)     3,715       1,824       (376 )     (7,657 )     (2,599 )
                                         
Other income (expense):                                        
Interest     (85 )     34             291       240  
Other     126       (98 )           41       69  
Foreign exchange loss           (308 )                 (308 )
Income (loss) before income taxes   $ 3,756     $ 1,452     $ (376 )   $ (7,430 )   $ (2,598 )
                                         
Depreciation and amortization included above   $ 1,185     $ 1,432     $     $ 75     $ 2,692  
                                         
Share-based compensation included in above:                                        
Cost of clinical laboratory services   $ 5                       $ 5  
Selling, general and administrative     74     $ 49           $ 473       596  
Total   $ 79     $ 49     $     $ 473     $ 601  
                                         
Capital expenditures   $ 1,070     $ 354     $     $     $ 1,424